Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants

被引：0
|
作者：
Sbrana, Francesco [1 ]
Ripoli, Andrea [1 ]
Dal Pino, Beatrice [1 ]
机构：
[1] Fdn Toscana Gabrielel Monasterio, Pisa, Italy
来源：
ACTA CARDIOLOGICA | 2022年 / 77卷 / 06期
关键词：
D O I：
10.1080/00015385.2021.1962623
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：565 / 565
页数：1
相关论文
共 50 条
  • [41] Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
    Potpara, Tatjana S.
    Lip, Gregory Y. H.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (11): : 1115 - 1116
  • [42] Oral Anticoagulation in Japanese Patients With Atrial Fibrillation - Insight to the Use of Non-Vitamin K Antagonist Oral Anticoagulants
    Gomez-Molina, Miriam
    Valdes, Mariano
    Marin, Francisco
    [J]. CIRCULATION JOURNAL, 2015, 79 (02) : 292 - 294
  • [43] Adherence to oral anticoagulant therapy in patients with atrial fibrillation Focus on non-vitamin K antagonist oral anticoagulants
    Raparelli, Valeria
    Proietti, Marco
    Cangemi, Roberto
    Lip, Gregory Y. H.
    Lane, Deirdre A.
    Basili, Stefania
    [J]. THROMBOSIS AND HAEMOSTASIS, 2017, 117 (02) : 209 - 218
  • [44] Comparative Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulants for Patients with Nonvalvular Atrial Fibrillation
    Senoo, Keitaro
    Lip, Gregory Y. H.
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (02): : 146 - 153
  • [45] Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
    Steven Deitelzweig
    Allison Keshishian
    Amiee Kang
    Amol D. Dhamane
    Xuemei Luo
    Christian Klem
    Lisa Rosenblatt
    Jack Mardekian
    Jenny Jiang
    Huseyin Yuce
    Gregory Y. H. Lip
    [J]. Advances in Therapy, 2021, 38 : 3166 - 3184
  • [46] The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
    Grymonprez, Maxim
    Petrovic, Mirko
    De Backer, Tine L.
    Steurbaut, Stephane
    Lahousse, Lies
    [J]. THROMBOSIS AND HAEMOSTASIS, 2024, 124 (02) : 135 - 148
  • [47] Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Hu, Mu-Mei
    Wang, Jui
    Chien, Kuo-Liong
    Su, Chin-Ling
    Lin, Shin-Yi
    Wu, Fe-Lin Lin
    Lin, Zhen-Fang
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (04) : 276 - 286
  • [48] Efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and hypertrophic cardiomyopathy
    刘圆圆
    [J]. China Medical Abstracts (Internal Medicine), 2022, (02) : 100 - 100
  • [49] Eligibility criteria for non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in the real world
    Augusto, J. B.
    Santos, M. Borges
    Roque, D.
    Silva, M.
    Castro, J.
    Sala, J.
    Faustino, A.
    Branco, M.
    Morais, J.
    Morais, C.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 236 - 236
  • [50] Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer
    Kim, Kyu
    Lee, Yong-Joon
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Joung, Boyoung
    [J]. KOREAN CIRCULATION JOURNAL, 2018, 48 (05) : 406 - 417
12345